Sign in

CIK 0001806310 · Non-accelerated filer<br>Smaller reporting company

Taysha Gene Therapies, Inc.

Sign in to watch
Ticker
TSHA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
843199512
Phone
(214) 612-0000
Business address
3000 PEGASUS PARK DRIVE, SUITE 1430, DALLAS, TX, 75247
  1. DEF 14A Proxy Proxy Statement
  2. 4/A Insider Changes in Ownership
  3. PRE 14A Proxy Proxy Statement (Preliminary)
  4. 4 Insider Changes in Ownership
  5. 10-K Report Annual Report
  6. 8-K Event Results of operations
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. SCHEDULE 13G Stake Statement of Beneficial Ownership
  10. SCHEDULE 13G Stake Statement of Beneficial Ownership
  11. S-8 Other Securities Offered to Employees in Benefit Plans
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. EFFECT Other Notice of Effectiveness
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. CORRESP Other Correspondence Between Filers and SEC Staff
  18. UPLOAD Other SEC-generated Letter
  19. S-3 Offering Registration Statement
  20. SC 13G/A Stake Amended Statement of Ownership

Page 6 of 21 · 403 filings